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ABSTRACT
We report a system for the efficient removal of a
marker flanked by two loxP sites in Streptomyces
coelicolor, using a derivative of the temperate
phage fC31 that expresses Cre recombinase during
a transient infection. As the test case for this recom-
binant phage (called Cre-phage), we present the
construction of an in-frame deletion of a gene,
pglW, required for phage growth limitation or Pgl
in S.coelicolor. Cre-phage was also used for marker
deletion in other strains of S.coelicolor.
INTRODUCTION
Bacteria in the genus Streptomyces are important producers of
antibiotics and other pharmacologically active compounds.
These bacteria are also important model organisms for bac-
terial development, as they have a mycelial growth habit and a
sporulation phase. Streptomyces spp. are relatively easy to
manipulate genetically, thanks to tried and tested methods
and customized tools accumulated over the years (1–3).
Recently the application of the l Red recombination proteins
to manipulate the ordered Streptomyces coelicolor cosmid
library in Escherichia coli has greatly facilitated the construc-
tion of targeted mutants (2). Adaptations to the original pro-
cess as described by Datsenko and Wanner (4) have tuned the
materialsandproceduresfortheir speciﬁc useinStreptomyces,
and this approach is known as the REDIRECT system (2). As
with the original Datsenko and Wanner procedure many of the
targeting cassettes for REDIRECT are constructedto allow the
use of the FLP/frt recombination system for optional marker
removal (4). All that is left after FLP/frt recombination is an
81 bp ‘scar’ containing one frt site and the cassette primer-
binding sequences. The drawback in the REDIRECT system is
that FLP/frt recombination currently has to be performed in
E.coli, after which the unmarked cosmid is introduced into
Streptomyces by protoplast transformation, or manipulated
further to introduce an oriT for conjugation. Attempts to
clone the FLP determinant into Streptomyces phage or plasmid
vectors have not been successful (C. Bruton, personal com-
munication), possibly due to the very high A+T content of the
FLP gene.
We present here the use of the Cre-loxP system from bac-
teriophage P1 for marker removal in Streptomyces. In the new
system, the Cre determinant is introduced into Streptomyces
during infection by an engineered derivative (‘Cre-phage’) of
fC31, a bacteriophage that has been widely studied as a model
temperate phage of Streptomyces, and extensively exploited as
acloningvector(1). As atestcaseforthisnew toolwechose to
construct an in-frame deletion in a gene, pglW, whose product
is thought to be required for the phage growth limitation (Pgl)
system in S.coelicolor A3(2) (5). The Pgl system is charac-
terized by inability of phages of the fC31 family to form
plaques on wild-type (i.e. Pgl
+) S.coelicolor including the
M145 strain used here. This bacterium encodes two closely
located operons, pglWX and pglYZ, that were shown previ-
ously to confer the Pgl phenotype (5). Currently the mechan-
ism of Pgl is not understood, but bioinformatic analysis of
the predicted gene products suggests that PglW is a serine-
threonine protein kinase, PglX is a DNA adenine methyltrans-
ferase, PglY is an ATPase and PglZ is a protein of unknown
function. As both pglW and pglY are the ﬁrst genes in their
respective two-gene operons, the availability of in-frame gene
knockouts is a requirement for further analysis of this system.
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doi:10.1093/nar/gnj019Although an in-frame deletion of part of the pglY ORF had
been constructed previously (6), we had not been able to
construct an in-frame deletion of pglW (5). The requirement
for pglW in the Pgl system was inferred using an insertion in
pglW, which could have also prevented expression of pglX due
to polarity. Therefore, to complement the pglX requirement in
the pglW insertion mutant, a second copy of pglX was intro-
duced ectopically expressed from the ptipA promoter (5).
Although this strain was Pgl
  there was still the possibility
that the phage sensitivitywas due to incomplete complementa-
tion of pglX. We show here, using Cre-phage for marker
removal, that an in-frame deletion of pglW is indeed Pgl
 
and can be complemented by addition of a wild-type allele
of pglW.
MATERIALS AND METHODS
Bacterial strains
E.coli DH5a was used as a general cloning host (7) and E.coli
BW25113(pIJ790) was used for the l Red recombination
reactions (2). S.coelicolor strain M145 was used as the parent
strain for the generation of the DpglW (SLMW41-4) and DpglY
(SLMY43 and SLMY44) mutants. J1929 [pglY
 ; (6)] was
used as an indicator strain for fC31 derivatives KC515 and
Cre-phage.
Bacteriophages and plasmids
A derivative of the fC31-based cloning vector KC515 (1) was
constructed that contained an allele of cre that had been
manipulated for expression during phage infection. The
cre gene was ampliﬁed by PCR using Expand High
Fidelity Polymerase (Roche Molecular Biochemicals), accor-
ding to the manufacturer’s instructions and with p705-Cre (8)
as a template. The annealing temperature was 55 C. The
upstream primer, SL6 (Table 1), was designed to introduce
a ribosome-binding site and a phage-speciﬁc promoter known
to be activated during lytic growth (9). The downstream pri-
mer was SL5 (Table 1). The modiﬁed cre gene was cloned
initially into the TA vector, pDK101, cut with XmnI (10) to
form pSL36, and then excised via PstI and HpaI restriction
sites and inserted into KC515 cut with PstI and ScaI to form
Cre-phage. A high titre stock of Cre-phage was prepared using
S.coelicolor J1929 as an indicator strain and using the plate
soak out method as described in Kieser et al. (1).
To test the activity and efﬁciency of Cre-phage in marker
removal via Cre-loxP recombination we constructed a mutant
pglW using a novel cassette vector, pIJ774, for REDIRECT
(2). This plasmid contains loxP sites ﬂanking the aac3(IV)
marker encoding apramycin resistance and the oriT site.
The apramycin resistance marker aac(3)IV and the origin of
transfer oriT from RK2 were jointly ampliﬁed from the 1383
bp EcoRI/HindIII pIJ773 disruption cassette (2) with primers
774FLOXP and 774RLOXP (Table 1). Ampliﬁcation was per-
formed as described previously (2). The resulting 1363 bp
fragment was inserted into the EcoRV sites of pBluescript
II SK(+), resulting in pIJ774. Sequence analysis revealed a
single base pair deletion of a ‘G’ within the primer sequence,
P1, of pIJ774 so that the sequence is 50-ATTCCGGGATC-
CGTCGACC. In the REDIRECT procedure P1 and P2 are
used to prime ampliﬁcation of the cassettes encoding the
markers/oriT. Despite the sequence change in pIJ774, the ori-
ginal P1 sequence (50-ATTCCGGGGATCCGTCGACC) was
used forthe primers, LJM5 and LJM6, in this work. Ultimately
the deletion inthepIJ774P1sequencehadnoadverseeffecton
formation of the scar sequence, i.e. no unwanted frameshifts
were introduced (see below). Our current experiments employ
a modiﬁed P1 sequence (P1774 50-TATTCCGGGATCC-
GTCGACC).
RESULTS AND DISCUSSION
The pglW gene is located on cosmid SC1F2 (11,12). pIJ774
was used as a template in a PCR with primers LJM5 and LJM6
to generate the recombination substrate for replacement of
pglW in SC1F2. Primers were designed using the BMW soft-
wareprovidedwiththeREDIRECTsystem (13).Theinitiation
codon, GTG, for pglX was replaced with the more efﬁcient
ATG to compensate for the removal of a putative ribosome-
binding site during deletion. An alternative strategy for primer
design would have been to move the deletion end point 21 bp
upstream thus leaving in place the putative translational sig-
nals for optimal expression of pglX. The PCR products were
digested with DpnI overnight (37 C) and then introduced by
electroporation into BW25113(pIJ790) containing SC1F2 (2).
About 70% of the apramycin resistant colonies obtained con-
tained mutant cosmids. Two independently mutated cosmids,
SC1F2::DpglW41 and SC1F2::DpglW42, were introduced into
ET12567 (pUZ8002) and transferred to S.coelicolor M145
by conjugation, selecting for apramycin resistance (1).
Apramycin-resistant, kanamycin-sensitive clones were sub-
cultured and tested for phage resistance. All of the
apramycin-resistant, kanamycin-sensitive clones tested sup-
ported plaque formation with fC31 and were therefore
Pgl
 . Two clones, SLMW41 and SLMW42, derived from
each of the two independently mutated cosmids, were chosen
for marker removal with Cre recombinase.
Table 1. Oligonucleotides
Oligonucleotide Sequence
SL6 50-GAAGCCCGGGTGAGCCGGGTTGCCGACTCCCTTACGGGTCCCTGAGAGCAACTACGAAGGGGAGTCAGTATGTCCAA
TTTCCTGACCGTACACCAAAATTTG
SL5 50-TTACGCGTTAACGGCTAATCGCCATCTTCCAGCAGGCGC
774FLOXP 50-TGTAGGCTGGAGCTGCTTCGATAACTTCGTATAATGTATGCTATACGAAGTTATGGAATAGGAACTTATGAGCTC
774RLOXP 50-ATTCCGGGGATCCGTCGACCCATAACTTCGTATAGCATACATTATACGAAGTTATGAAGTTCCCGCCAGCCTCGC
LJM5 50-GCGGTCCTTGAAGGACACGAGGAGCGGGGAACAGGCATGATTCCGGGGATCCGTCGACC
LJM6 50-GCTGCTTCAGGTCGTTCAACAGAGCCTTGCGGTCGATCATGTAGGCTGGAGCTGCTTC
LJM11 50-CGGACGCCTATCCACTCACC
LJM12 50-ACCTCATCGAGCGCCTTCAC
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P2 P2
loxP loxP
oriT oriT aac3(IV) aac3(IV)
pglW pglW pglX pglX
pglX pglX
pglX pglX
loxP loxP
loxP loxP
oriT oriT aac3(IV) aac3(IV)
loxP loxP
 
 
loxP loxP
 
pIJ774 loxP disruption
cassette
SCE1F2 cosmid DNA
∆pglW::aac3(IV)/oriT in 
SCE1F2, SLMW41 & SLMW42 
∆pglW in SLJMW43 & SLJMW44 
  
i
ii
iii
P1 P1
P1 P1
P2 P2
P2 P2
A
B
C
GGGAACAGGCATGATTCCGGGGATCCGTCGACCCATAACTTCGTATAGCATACATTA
            M  I  P  G  I  R  R  P  I  T  S  Y  S  I  H  
  
TACGAAGTTATCGAAGCAGCTCCAGCCTACATGATCGACCGCAA
Y  T  K  L  S  K  Q  L  Q  P  T  - 
  ∆pglW
507 bp
1794 bp
M M M145
SLJMW 4 1
SLJMW 4 2
SLJMW 4 3 clones
SLJMW 4 4 clones
a    b     c     d a    b     c     d
>>>>>>>>>>>>>>>>>>>  **********************
*********** <<<<<<<<<<<<<<<<<<<
  pglX
M  I  D  R    
Figure1.DeletionofpglWinM145.(A)Schematicrepresentationshowing(i)theuseofthepIJ774REDIRECTdisruptioncassetteinthegenerationofaDpglWgene
replacement,(ii)theorganizationoftheSC1F2::DpglWgenereplacementinthemutatedcosmids,SC1F2::DpglW41andSC1F2::DpglW42,andintheex-conjugants
SLMW41 and SLMW42 and (iii) the remaining loxP site after removal of aac3(IV)/oriT using Cre-phage. The black arrowheads represent the loxP sites and are in
direct repeat; the arrows P1 and P2 show the locations of the primer-binding sites used to amplify the REDIRECT cassette from pIJ774 with the custom primers.
(B) PCR amplification of the pglW region from the various strains of S.coelicolor generated using the REDIRECT/Cre-phage method. SLMW41 and SLMW42 are
two independently isolatedex-conjugants from ET12567(1 SC1F2::DpglW41) and ET12567(1 SC1F2::DpglW42) conjugationwith M145. SLMW43 clones a-d and
SLMW44 clones a-d are derivatives from SLMW41 and SLMW42, respectively, that have survived Cre-phage infection and have lost the apramycin resistance
marker.TheexpectedPCRproductsofthepglWlocusamplifiedusingtheprimersLJM11andLJM12are5099bpwhenM145isthetemplate,1794bpwithSLMW41
andSLMW42astemplatesand507bpwithSLMW43clonesa-dandSLMW44clonesa-dastemplates.Themarkersarethe100bpladderfromnewEnglandBiolabs.
Arrows indicate the expected positions of the 1794 and 507 bp fragments. The predicted 5099 bp product from M145 was not observed, probably because the
conditionsforPCRprecludedsynthesisofsuchalargeproduct.(C)DNAsequenceofthescarsequence obtainedfromSLMW43cloneaandSLMW44cloneb.The
initiation codon for pglW initiates the synthesis of a 26 amino acid peptide (sequence shown below the DNA sequence) ending in a termination codon, TGA, that
overlapswiththeinitiationcodon,ATGforpglX.ThearrowheadsandasterisksabovetheDNAsequenceshowthecassetteprimersequences,P1andP2,andtheloxP
site, respectively.
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KC515, a derivative of the phage fC31 (1). KC515 has a
functional phage repressor and a defective int gene, encoding
the integrase, and no attP site. This should result in some
phage infections that enter the lysogenic pathway but fail to
persist as stable lysogens. It is not clear in fC31 infections at
what point the decision is made to enter lysogeny. The devel-
opmental cycle begins with transcription of the early lytic
genes from early promoters (9,14,15). It is likely that at
some point during early lytic growth a decision between
lysis and lysogeny is made and the phage repressor shuts
down lytic transcription resulting in cessation of DNA rep-
lication (16). As KC515 (and Cre-phage) has no efﬁcient
means of integration into the host chromosome, the phage
DNA will virtually always be lost by dilution or nucleolytic
activity. In addition, a proportion of cells within fC31 plaques
survive infection through some ill-deﬁned phenotypic resist-
ance. Thus there are at least two routes by which cells infected
by Cre-phage might survive yet have experienced a burst of
Cre synthesis. Approximately 10
7 spores of SLMW41 and
SLMW42 were plated on R2YE plates and 5 · 10
6 p.f.u.
(in 100 ml) of Cre-phage were inoculated onto the centre of
each plate. After overnight incubation the areas of slightly
reduced growth, indicative of phage infection, were marked
on the base of the plates. Incubation was continued until a
whitish layer of spores appeared within the infected areas. The
spores were harvested in sterile water, and 10-fold dilutions
were plated on mannitol soya (MS) medium. Replica-plating
of plates containing between 15 and 60 colonies onto NA
plates with or without apramycin was used to identify
apramycin-sensitive colonies. The frequency of apramycin-
sensitive clones varied from  30 to  60%. Eight apramycin
sensitive colonies, SLMW43 clones a–d and SLMW44 clones
a-d,derived fromCre-phage-infected SLMW41andSLMW42,
respectively, were subcultured and genomic DNA samples
were prepared. PCR, using primers LJM11 and LJM12, gen-
erated an expected product of 507 bp from SLMW43 clones
a-d and SLMW44 clones a-d and 1794 bp from SLMW41 and
SLMW42 genomic DNA templates (Figure 1B). The 507 bp
product was sequenced from four isolates and found to contain
the expected scar sequence of 81 bp (Figure 1B). The super-
natants from spore preparations of SLMW43 clones a-d and
SLMW44 clones a-d were tested for any remaining phage by
plating with indicator spores, but no plaques were obtained,
indicating that Cre-phage failed to persist through subculture.
When this assay is performed with a spore preparation of a
fC31 lysogen, the titre is usually between 10
3–10
4 pfu/ml
(M.C.M. Smith, unpublished data). SLMW43 clones a-d
and SLMW44 clones a-d were able to plaque fC31, and
could be complemented to phage resistance by integration
of pPS8002 encoding PglW fused to 6· His tag and expressed
from ptipA (5) (Figure 2). This experiment provided proof that
pglW is indeed required for Pgl. We have also used this tech-
nique to generate knockout mutations of the complete pglY
ORF (SLMY43 and SLMY44).
This simple and reliable technique for marker removal
greatly facilitates the construction of in-frame, unmarked
mutants in Streptomyces.A sfC31 has a fairly broad
host range within the genus Streptomyces [(17,18) and
D. Cowlishaw and M. C. M. Smith, unpublished data],
Cre-phage should be applicable to many species. Although
we have used the technique for marker removal in a Pgl
 
strain that can support plaque formation by fC31 and deriv-
atives, it can also be used in Pgl
+ strains. This is because fC31
(and therefore Cre-phage) prepared from a Pgl
  strain can
undergo a full lytic cycle in a Pgl
+ strain releasing progeny
phage. However multiplication of this progeny phage in
further infectious cycles is severely attenuated resulting in
an inability to form plaques (19). To demonstrate the use of
Cre-phage in the Pgl
+ strain S.coelicolor M145, SCO6073, the
putative cyclase, cyc2, previously shown to be required for
biosynthesis of geosmin (2), was deleted. Using the same
primers as described previously [(2) Sc9B1.20forw and
Sc9B1.20rev] and pIJ774 as a template, SCO6073 was
replaced in cosmid SC9B1 with apramycin/oriT ﬂanked by
the two loxP sites. Apramycin-resistant, kanamycin-sensitive
exconjugants were treated with Cre-phage and an infected
zone couldstillbediscernedafterovernightincubation.Spores
from the infected area were streaked on MS for single colon-
ies. Replica plating onto DNA plates with and without apra-
mycin revealed the loss of the resistance marker in  90% of
colonies. DNA of three apramycin-sensitive mutants was ana-
lysed by PCR using primers 9B1.20T1 and 9B1.20T2 (2)
resulting in a PCR product of 1353 bp (data not shown).
This fragment was sequenced and the loxP-scar was identical
to the scar sequence in Figure 1. Cre-phage has also been
used by others for marker removal in a derivative of M145
(F. Barona-Gomez and G. Challis, personal communication).
M145 SLMW43 SLMW43(pPS8002)
Figure2.PhagesensitivityoftheSLMW43DpglWstrain.Difconutrientagarplatescontaining10mMMgSO4and8mMCa(NO3)2wereinoculatedwith 300p.f.u.
of fC31cD25 (22) and overlaid with soft nutrient agar containing M145, SLMW43 or SLMW43(pPS8002) spores. pPS8002, constructed previously, integrates into
the attB site for fC31 and encodes a functional pglW allele expressed from the ptipA promoter (5).
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‘scar’ containing a loxP site, and this could potentially be a
target for undesirable rearrangements, if one should need to
generate multiple mutants. Whilst the transient nature of Cre
expression from Cre-phage will help to minimize recombina-
tion between distant loxP sites, a more effective deterrent to
these unwanted rearrangements would be for the genomic
interval to contain an essential gene. Another way to solve
this problem would be to incorporate variant loxP sites into the
REDIRECTcassettes that canonly recombine with each other,
e.g. lox2722 recombines efﬁciently with another lox2722 but
not with a loxP site (20,21). Furthermore, there may be occa-
sions when one might wish to make two knockouts in the same
cosmid in E.coli. One way of doing this may be to combine the
use of the FLP/frt and Cre/loxP. The ﬁrst mutation could be
made using the FLP/frt sites on the REDIRECT cassette,
pIJ773, and the second mutation made using the pIJ774 cas-
sette. The doubly mutated cosmid would then be transferred to
Streptomyces by conjugation selecting for apramycin resist-
ance, and Cre-phage used to remove the marker. Overall the
use of Cre-phage in marker removal represents an improve-
ment to the current use of the FRT/ﬂp and adds further ver-
satility to the REDIRECT system.
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